Nimbus Therapeutics Publishes First-Ever High-Resolution Structure of ATP-Citrate Lyase
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 3, 2019--Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today…